Eu Ivdd Eu Ivd General On The Market 🇰🇷 South Korea

VEUPLEX™ TBI assay

EzDiaTech, Inc. · 🇰🇷 South Korea
Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
08809901510067
Basic UDI-DI Code
B-08809901510067
Reference
EZ-TBIV
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market
Manufacturer
EzDiaTech, Inc.

Additional Description

VEUPLEX™ TBI assay is intended to be used for quantitative detection of multiple biochemical markers named GFAP (Glial fibrillary acidic protein, hereinafter GFAP) and UCHL1 (Ubiquitin carboxyl-terminal hydrolase L1, hereinafter UCHL1) in a serum of patients suspected of traumatic brain injury(intracranial injury) and a semiquantitative interpretation of test results, using fluorescence immunoassay method in order to monitor the patients before/without a neuroimaging radiological scan following head injury. This product is for professional use only.

CND Nomenclature Codes

Code Description
W0102019099 SPECIFIC PROTEINS - OTHER

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all